| Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity (NCT05522764) | Fondation Hôpital Saint-Joseph | 2022-07-18 |
| Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort Study (NCT05152225) | the Jeunes en Neuroradiologie Interventionnelle (JENI) research group | 2022-01-01 |
| Anemia in Patients With Endocarditis (NCT04840225) | Rigshospitalet, Denmark | 2021-03-22 |
| Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis (NCT04222257) | Carmen Olmos Blanco | 2021-01-26 |
| Barts Endocarditis Research Registry (NCT06434012) | Queen Mary University of London | 2019-04-24 |
| Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis (NCT03048643) | Laura Fanucchi | 2017-03-01 |
| Fosfomycin I.v. for Treatment of Severely Infected Patients (NCT02979951) | Infectopharm Arzneimittel GmbH | 2016-12-01 |
| Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients (NCT03306225) | Fondation Hôpital Saint-Joseph | 2016-07-08 |
| Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia (NCT00695903) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2008-09-17 |
| How to Improve Diagnosis in Infective Endocarditis (NCT00524212) | University of Aarhus | 2007-03-01 |
| Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis. (NCT00401960) | Weill Medical College of Cornell University | 2006-09-01 |
| IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis (NCT00144885) | Assistance Publique - Hôpitaux de Paris | 2005-06-01 |